Phosphodiesterase inhibitors - PubMed (original) (raw)
Review
Phosphodiesterase inhibitors
Victoria Boswell-Smith et al. Br J Pharmacol. 2006 Jan.
Abstract
Phosphodiesterases are a diverse family of enzymes that hydrolyse cyclic nucleotides and thus play a key role in regulating intracellular levels of the second messengers cAMP and cGMP, and hence cell function. Theophylline and papaverine have historically been used therapeutically and are known to be weak inhibitors of PDE, but to what extent this contributed toward their clinical efficacy was poorly defined. However, the discovery of 11 isoenzyme families and our increased understanding of their function at the cell and molecular level provides an impetus for the development of isoenzyme selective inhibitors for the treatment of various diseases. This review focuses on the development of PDE3 inhibitors for congestive heart failure, PDE4 inhibitors for inflammatory airways disease and most successfully, PDE5 inhibitors for erectile dysfunction.
Figures
Figure 1
Inhibition of cAMP-PDE activity by methylxanthines. cAMP was incubated with purified cAMP-PDE at 30°C for 30 min in the presence of increasing concentrations of methylxanthines. Data redrawn from Butcher & Sutherland (1962).
Figure 2
The PDE5 inhibitor M&B 22,949 (Zaprinast) augmented relaxation of human corpus cavernosum to electrical field stimulation (Hz). Data showing relaxation of human corpus cavernosum in an isolated preparation (a) or the mean±s.e.m. for 11 subjects (b); to different stimulation frequencies in untreated and M&B 22,949 (1–3 m
M
)-treated tissue. Data re-drawn from Raijfer et al. (1992).
Similar articles
- Phosphodiesterase inhibitors in airways disease.
Fan Chung K. Fan Chung K. Eur J Pharmacol. 2006 Mar 8;533(1-3):110-7. doi: 10.1016/j.ejphar.2005.12.059. Epub 2006 Feb 2. Eur J Pharmacol. 2006. PMID: 16458289 Review. - Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
Ko WC, Shih CM, Lai YH, Chen JH, Huang HL. Ko WC, et al. Biochem Pharmacol. 2004 Nov 15;68(10):2087-94. doi: 10.1016/j.bcp.2004.06.030. Biochem Pharmacol. 2004. PMID: 15476679 - Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure.
Stehlik J, Movsesian MA. Stehlik J, et al. Expert Opin Investig Drugs. 2006 Jul;15(7):733-42. doi: 10.1517/13543784.15.7.733. Expert Opin Investig Drugs. 2006. PMID: 16787138 Review. - Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
Rutten K, Prickaerts J, Hendrix M, van der Staay FJ, Sik A, Blokland A. Rutten K, et al. Eur J Pharmacol. 2007 Mar 8;558(1-3):107-12. doi: 10.1016/j.ejphar.2006.11.041. Epub 2006 Dec 1. Eur J Pharmacol. 2007. PMID: 17207788 - Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
Kass DA. Kass DA. Circulation. 2007 Jul 17;116(3):233-5. doi: 10.1161/CIRCULATIONAHA.107.710988. Circulation. 2007. PMID: 17638937 No abstract available.
Cited by
- In Vitro Inhibition of Phosphodiesterase 3B (PDE 3B) by Anthocyanin-Rich Fruit Juice Extracts and Selected Anthocyanins.
Göttel C, Niesen S, Daub V, Werle T, Bakuradze T, Winterhalter P, Richling E. Göttel C, et al. Int J Mol Sci. 2020 Sep 21;21(18):6934. doi: 10.3390/ijms21186934. Int J Mol Sci. 2020. PMID: 32967310 Free PMC article. - Sildenafil Inhibits Myelin Expression and Myelination of Oligodendroglial Precursor Cells.
Muñoz-Esquivel J, Göttle P, Aguirre-Cruz L, Flores-Rivera J, Corona T, Reyes-Terán G, Küry P, Torres KJ. Muñoz-Esquivel J, et al. ASN Neuro. 2019 Jan-Dec;11:1759091419832444. doi: 10.1177/1759091419832444. ASN Neuro. 2019. PMID: 30849920 Free PMC article. - Milrinone relaxes pulmonary veins in guinea pigs and humans.
Rieg AD, Suleiman S, Perez-Bouza A, Braunschweig T, Spillner JW, Schröder T, Verjans E, Schälte G, Rossaint R, Uhlig S, Martin C. Rieg AD, et al. PLoS One. 2014 Jan 31;9(1):e87685. doi: 10.1371/journal.pone.0087685. eCollection 2014. PLoS One. 2014. PMID: 24498166 Free PMC article. Clinical Trial. - Sildenafil enhances locomotor activity in young mice and exerts anxiogenic effects in both young and aged mice.
Demirci D, Mutlu O, Akar F, Komsuoglu Celikyurt I, Ulak G. Demirci D, et al. Med Sci Monit Basic Res. 2014 Feb 5;20:15-21. doi: 10.12659/MSMBR.890280. Med Sci Monit Basic Res. 2014. PMID: 24500039 Free PMC article. - A computational study of hedgehog signalling involved in basal cell carcinoma reveals the potential and limitation of combination therapy.
Buetti-Dinh A, Jensen R, Friedman R. Buetti-Dinh A, et al. BMC Cancer. 2018 May 18;18(1):569. doi: 10.1186/s12885-018-4451-1. BMC Cancer. 2018. PMID: 29776351 Free PMC article.
References
- ALLENBY K.S., BURRIS J.F., MROCZEK W.J. Pentoxifylline in the treatment of vascular impotence – case reports. Angiology. 1991;42:418–420. - PubMed
- ASHMAN D.F., LIPTON R., MELICOW M.M., PRICE T.D. Isolation of adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate from rat urine. Biochem. Biophys. Res. Commun. 1963;11:330–334. - PubMed
- BALLARD S.A., GINGELL C.J., TANG K., TURNER L.A., PRICE M.E., NAYLOR A.M. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J. Urol. 1998;159:2164–2171. - PubMed
- BARBER R., BAILLIE G.S., BERGMANN R., SHEPHERD M.C., SEPPER R., HOUSLAY M.D., HEEKE G.V. Differential expression of PDE4 cAMP phosphodiesterase isoforms in inflammatory cells of smokers with COPD, smokers without COPD, and non smokers. Am. J. Physiol. Lung Cell Mol. Physiol. 2004;287:L332–L343. - PubMed
- BARNES P.J., CHUNG K.F., PAGE C.P. Inflammatory mediators and asthma. Pharmacol. Rev. 1988;40:49–84. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources